Dr. Thomas S. White, M.D.
Pain Medicine (Interventional Pain Medicine Physician)
111 Vision Park Blvd Ste 100
Shenandoah, TX 77384
Who else practices at this address →
Montgomery County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Texas Medical Branch at Galveston (2013)
- Years since graduation
- 13
- In the NPI registry since
- 2013
- Medicare patients seen, 2024
- 188
Licensed in Texas since 2018, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2013Medical school: University of Texas Medical Branch at Galveston
- 2013Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Pain Medicine Physician primary
TX license R6132 (first issued 2018; active) -
Pain Medicine (Anesthesiology) Physician
TX license R6132 (first issued 2018; active) -
Pain Medicine Physician
TX license R6132 (first issued 2018; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Memorial Hermann Hospital System Houston, TX
- Houston Methodist the Woodlands Hospital The Woodlands, TX
- Memorial Hermann Memorial City Hospital Houston, TX
- Aspire Hospital Conroe, TX
Medical groups
- Champion Anesthesia Consultants PLLC (12 clinicians)
- Procura PAin and Spine, PLLC (6 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 188
- Services billed
- 10,240
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 1,325 | 187 |
| Testing for presence of drug, read by direct observation | 1,190 | 188 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,142 | 79 |
| Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | 1,066 | 176 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 766 | 189 |
| Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, first 20 minutes per calendar month | 336 | 48 |
| Device supply with scheduled recording and transmission for remote monitoring of musculoskeletal system, per 30 days | 310 | 44 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 236 | 39 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 234 | 110 |
| Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, each additional 20 minutes per calendar month | 217 | 44 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Shenandoah, TX | 1,815 |
| Pregabalin Other prescribers in Shenandoah, TX | 1,056 |
| Cyclobenzaprine Hcl Other prescribers in Shenandoah, TX | 697 |
| Tizanidine Hcl Other prescribers in Shenandoah, TX | 554 |
| Gabapentin Other prescribers in Shenandoah, TX | 499 |
| Oxycodone-Acetaminophen (oxycodone hcl/acetaminophen) Other prescribers in Shenandoah, TX | 467 |
| Meloxicam Other prescribers in Shenandoah, TX | 418 |
| Oxycodone Hcl Other prescribers in Shenandoah, TX | 303 |
| Trazodone Hcl Other prescribers in Shenandoah, TX | 294 |
| Methocarbamol Other prescribers in Shenandoah, TX | 250 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 52 payments worth $3,445 in total to this clinician.
| Abbott Laboratories | $1,421 |
|---|---|
| Globus Medical, Inc. | $1,321 |
| Medtronic, Inc. | $328 |
| Indivior Inc. | $93.05 |
| Nalu Medical, Inc. | $52.55 |
| Axsome Therapeutics, Inc. | $50.52 |
| Mml US, Inc. | $47.50 |
| Azurity Pharmaceuticals, Inc. | $42.53 |
| Food and Beverage | $1,837 |
|---|---|
| Consulting Fee | $1,100 |
| Travel and Lodging | $508 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Globus Medical, Inc. Mar 27, 2025 | Consulting Fee Senza · SPINAL CORD STIMULATOR | $1,100 |
| Abbott Laboratories Dec 18, 2025 | Travel and Lodging PROCLAIM · Structural Heart · travel to Minnetonka, MN · in-kind | $257 |
| Abbott Laboratories Dec 18, 2025 | Travel and Lodging PROCLAIM · Structural Heart · travel to Charleston, WV · in-kind | $153 |
| Abbott Laboratories Dec 18, 2025 | Travel and Lodging PROCLAIM · Structural Heart · travel to Boca Raton, FL · in-kind | $89.86 |
| Abbott Laboratories Dec 18, 2025 | Travel and Lodging PROCLAIM · Structural Heart · travel to Minnetonka, MN · in-kind | $9.02 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $9,810 in research payments for these studies, mostly to the institutions running them.
- A post-market, multicenter, prospective, clinical study to evaluate the Nevro1 Sacroiliac (SI) Transfixing and Fusion System for the treatment of sacroiliac joint dysfunction
Globus Medical, Inc. - A Multi-Center, Prospective Clinical Study investigating effectiveness of a novel administration of 10 kHz SCS Therapy
Globus Medical, Inc. - SENSE SCS
Medtronic, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.